Relmada Therapeutics Strengthens Board of Directors with Appointment of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool

By WebmasterDecember 20, 2019November 1st, 2024No Comments

Relmada Therapeutics Strengthens Board of Directors with Appointment of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool

Previous PostRide Health Raises $6.2 Million to Coordinate the Medical Transportation Ecosystem
Next PostVenatorx Pharmaceuticals Joins the Alliance for Biosecurity